Major shareholder Aprogen increases stake to 58.73% via third-party allotment

On 2026-04-28, Aprogen, the largest shareholder of Aprogen Biologics Inc., acquired 592,593 common shares via a third-party allotment, raising its stake from 56.88% to 58.73%, a 1.85%p increase
After acquisition, Aprogen holds 8,114,654 shares (58.72%), and with related parties total 8,116,115 shares (58.73%)
The allotment is approximately 590,000 shares, aimed at strengthening the largest shareholder's control and capital raising

ADVERTISEMENT (250px+)